Floatz logo

LAMOTRIGINE

Epilepsy, Partial

Dhaka Medical CollegeSmall moleculePhase 4 / ApprovedActive
BBB
79/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
68/ 100
Competitive Position
95/ 100

Competitive context

24 Active assets in the Epilepsy, Partial cohort.

Asset / SponsorPhaseRating
Eslicarbazepine Acetate
Sumitomo Pharma America, Inc.
Phase 4A
Pregabalin
Yung Shin Pharm. Ind. Co., Ltd.
Phase 4A
Oxcarbamezapine
Mario Negri Institute for Pharmacological Research
Phase 4A
Topamax
Mario Negri Institute for Pharmacological Research
Phase 4A
Lacosamide
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Phase 4A

View all 50 →

Same molecule, other indications

LAMOTRIGINE is also rated in:

epilepsy with generalized tonic-clonic seizuresDormant
BBB
Indicative ·
75 / 100
View asset →
bipolar disorderDormant
BBB
Indicative ·
74 / 100
View asset →
epilepsyDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →